You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Chapter title |
Pharmaceutical Nanotechnology
|
---|---|
Chapter number | 10 |
Book title |
Nanomedicine
|
Published by |
Springer, Singapore, January 2023
|
DOI | 10.1007/978-981-16-8984-0_10 |
Book ISBNs |
978-9-81-168983-3, 978-9-81-168984-0
|
Authors |
Sun, Tao, Li, Chufeng, Li, Xuwen, Song, Haolin, Su, Boyu, You, Haoyu, Zhang, Tongyu, Jiang, Chen |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Turkey | 1 | 3% |
Ireland | 1 | 3% |
Nigeria | 1 | 3% |
Unknown | 35 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 18% |
Student > Master | 4 | 11% |
Lecturer | 3 | 8% |
Student > Doctoral Student | 3 | 8% |
Student > Postgraduate | 2 | 5% |
Other | 4 | 11% |
Unknown | 15 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 13% |
Medicine and Dentistry | 5 | 13% |
Agricultural and Biological Sciences | 4 | 11% |
Biochemistry, Genetics and Molecular Biology | 4 | 11% |
Engineering | 4 | 11% |
Other | 3 | 8% |
Unknown | 13 | 34% |